Industry

Summary

The UK has a strong history in clinical research and the healthcare industry has made a significant contribution to this track record through the conduct of its research and development programmes in the NHS. The DRN, in partnership with the NIHR CRN CC and UKCRC is working to address the specific challenges and pressures faced by the healthcare industry in this area.

The NIHR CRN has established a dedicated Industry team to address the specific challenges and pressures faced by the healthcare industry in successfully delivering their research and development projects through the NHS. The NIHR CRN Industry team is working closely with the healthcare industries, the Department of Health, and NHS Trusts in identifying barriers to the delivery of clinical research in the UK, and formulating solutions and strategies to overcome these.

The Diabetes Research Network is tasked with developing a world-class infrastructure to ensure that high-quality research funded by both commercial and non-commercial organisations receives the support it needs to succeed. Such support will include investment in the expansion of dedicated clinical research staff within the NHS, and the development of standard procedures to ensure consistent best practice at network study sites through both study set up and conduct.

How the DRN can benefit industry

The DRN is able to support pharmaceutical/biotech companies (including contract research organisations; CROs) in a number of ways through its world-class infrastructure.

We are able to offer the following services:

  • Top level feasibility assessments of new studies
  • Provision of sites to participate in research studies with dedicated resources and research staff
  • The capacity to provide prompt and reliable assessment of study feasibility through well established links with network study sites
  • Facilitation of study site activation through the use of standardised agreements and costing processes for studies adopted by the networks
  • Rapid patient recruitment and delivery of high quality data for clinical studies
  • Guided access for companies to the array of clinical and healthcare research expertise available in the UK

The DRN follows the NIHR CRN's procedures and policies for feasibility and adoption.

If you would like more information on how the DRN is working with industry please contact: Dr Suki Balendra (Industry and Portfolio Lead) by email: s.balendra@imperial.ac.uk

Visit the Industry page of the NIHR CRN CC website

^Top